Etextbook 978-0849374968 Photodermatology (Basic and Clinical Dermatology)
Etextbook 978-0849374968 Photodermatology (Basic and Clinical Dermatology)
Etextbook 978-0849374968 Photodermatology (Basic and Clinical Dermatology)
https://ebookmass.com/product/978-0323261838-clinical-
dermatology/
https://ebookmass.com/product/etextbook-978-0323319676-andrews-
diseases-of-the-skin-clinical-dermatology/
https://ebookmass.com/product/etextbook-978-0824758332-
principles-and-practices-in-cutaneous-laser-surgery-basic-and-
clinical-dermatology/
https://ebookmass.com/product/etextbook-clinical-dermatology-e-
book-6th-edition/
eTextbook 978-1337098069 Understanding Normal and
Clinical Nutrition
https://ebookmass.com/product/etextbook-978-1337098069-
understanding-normal-and-clinical-nutrition/
https://ebookmass.com/product/etextbook-978-1627034890-pediatric-
hypertension-clinical-hypertension-and-vascular-diseases/
https://ebookmass.com/product/etextbook-978-0323321976-body-
shaping-skin-fat-and-cellulite-procedures-in-cosmetic-
dermatology-series/
https://ebookmass.com/product/etextbook-978-1608318056-visualdx-
essential-adult-dermatology-visualdx-the-modern-library-of-
visual-medicine/
https://ebookmass.com/product/etextbook-978-1285424637-
veterinary-clinical-procedures-in-large-animal-practices/
Series Introduction
During the past 25 years there has been a vast explosion of new information relating to the art
and science of dermatology, as well as fundamental cutaneous biology. Furthermore, this
information is no longer of interest to only the small but growing specialty of dermatology.
Clinicians and scientists from a wide variety of disciplines have come to recognize both the
importance of skin in fundamental biological processes and the broad implications of under-
standing the pathogenesis of skin disease. As a result, there is now a multidisciplinary and
worldwide interest in the progress of dermatology.
With these factors in mind, we have undertaken this series of books specifically oriented
to dermatology. The scope of this series is purposely broad, with books ranging from pure basic
science to practical, applied clinical dermatology. Thus, while there is something for everyone,
all volumes in this series will ultimately prove to be valuable additions to the dermatologist’s
library.
The latest volume in the series (No. 38), by Lim, Hönigsmann, and Hawk, presents a com-
prehensive and current review of photomedicine by world renowned authorities. The role
of photobiology in medicine has received increased emphasis in the past decade as a result
of considerable new information regarding the molecular biological effects of ultraviolet
light, its effect on the immune system, its role in the promotion of skin cancer, and its
abuse by profiteers who market suntan parlors. It is, therefore, critically important that
dermatologists, physicians in general, biologists, and public health scientists remain current
in photomedicine. I believe that Dr. Lim and his coeditors have produced a timely and
critically important addition to our series, which is both timely and comprehensive.
Alan R. Shalita, MD
Distinguished Teaching Professor and Chairman
Department of Dermatology
SUNY Downstate Medical Center
Brooklyn, New York, U.S.A.
Preface
Within the past 30 years photomedicine has developed from empiricism into one of the most
exciting fields in biomedical research. Studies on the effects of visible and ultraviolet radiation
on skin have led to a fruitful collaboration between basic scientists and clinicians. The success-
ful use of the new ultraviolet techniques for the treatment of skin disease, along with a rapidly
increasing understanding of the pathogenesis of photodermatoses, thereby markedly improv-
ing their treatment, have been the driving force for the development of a new subspecialty of
photodermatology. This now encompasses the diagnosis and treatment of sunlight-induced
disorders; all aspects of phototherapy, including the use of such new modalities as photody-
namic therapy for skin tumors and other diseases; as well as photoprotection, which continues
to evolve with the development of new generations of ultraviolet filters. In the past decade,
therefore, very significant advances have occurred throughout this novel subspecialty, particu-
larly in photoimmunology, molecular biology, and genetics. In more detail, these include better
recognition and understanding of:
. Acute and chronic effects of ultraviolet radiation on the skin: in vitro studies, animal
models, photoaging, and epidemiology of skin cancers;
. Clinical manifestation of photodermatoses: actinic prurigo, pin-head papule form of poly-
morphous light eruption, novel genetic mutations in porphyrias, and so on;
. Pathophysiology and treatment of photodermatoses: polymorphous light eruption, actinic
prurigo, chronic actinic dermatitis, xeroderma pigmentatosum, photo-exacerbated derma-
toses, and so on;
. The science of photoprotection: new ultraviolet filters, photoprotection by clothing, photo-
protection by oral agents, and so on;
. Phototherapy: narrowband ultraviolet B, ultraviolet A1, visible light;
. Topical photodynamic therapy;
. Medical and cosmetic applications of laser and similar radiation sources; and
. New insight on the use of laser and radiation sources on people of color.
In planning for this book, our vision as editors was to create a book that is comprehensive
and up-to-date, yet is user-friendly to its intended readers who are busy, practicing dermatol-
ogists, photodermatologists, and trainees in dermatology. The editors are pleased that recog-
nized experts from many parts of the world willingly put in the effort and contributed most
informative chapters for this book.
The book consists of six sections. Section I is on history and basic principles, followed
by the effects of ultraviolet radiation on normal skin in Section II. Section III covers all the
photodermatoses, while Section IV and V discuss photoprotection and ultraviolet and visible
radiation therapy. Section VI is a practical description of testing methods used in photoderma-
tology and guidelines of setting up a phototherapy and laser center.
The three of us work in the United States, Europe, and the United Kingdom. We have
taken great care to make sure that materials covered in this book reflect an international
point of view. For example, international coverage is done on actinic prurigo (commonly
seen in Central and South America), photoprotection (different ultraviolet filters available in
different parts of the world), light sources and laser, and many other topics. It is our hope
that the readers will find that this book provides a good perspective on the worldwide scope
of photodermatology.
vi Preface
On a personal note, the three of us have been colleagues and friends for many years; all of
us have separately published books in photodermatology in the early and late 1990s. It has
been a real pleasure to combine our experience and to work on editing this book together.
We do hope that the readers will enjoy this book as much as we have enjoyed writing and
editing it.
Henry W. Lim, MD
Herbert Hönigsmann, MD
John L. M. Hawk, MD
Acknowledgments
Henry W. Lim would like to thank his parents, for providing him the opportunity to succeed,
and his wife Mamie, for her unending patience and support.
Hebert Hönigsmann would like to thank his wife Xandi, for tolerating the lack of care
and attention to the family during the preparation of this book.
John L. M. Hawk would like to thank his wife, Lorna, for her continuing tolerance and support,
as ever previously, throughout the preparation of this book.
The editors would like to thank Sandra Beberman and her team at Informa Healthcare for
working with us to produce this book.
Contents
5. Photoimmunology 55
Thomas Schwarz and Gary M. Halliday
27. The Principles and Medical Applications of Lasers and Intense-Pulsed Light in
Dermatology 389
Iltefat Hamzavi and Harvey Lui
28. Lasers and Energy Sources for Skin Rejuvenation and Epilation 401
Robert A. Weiss and Michael Landthaler
Index 463
Contributors
R. Rox Anderson Wellman Center for Photomedicine and Department of Dermatology, Harvard
Medical School, and Massachusetts General Hospital, Boston, Massachusetts, U.S.A.
Vincent A. DeLeo Columbia University, St. Luke’s– Roosevelt Hospital Center, New York,
New York, U.S.A.
Jeffrey S. Dover Department of Dermatology, Yale University School of Medicine, New Haven,
Connecticut, and Dartmouth Medical School, Hanover, New Hampshire, U.S.A.
Peter M. Farr Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne,
England, U.K.
Gary M. Halliday Dermatology Research Laboratories, Melanoma and Skin Cancer Research
Institute, University of Sydney, Sydney, Australia
Iltefat Hamzavi Department of Dermatology, Henry Ford Hospital, Detroit, and Hamzavi
Dermatology, Port Huron, Michigan, U.S.A.
John L. M. Hawk Photobiology Unit, St. John’s Institute of Dermatology, St. Thomas’ Hospital,
King’s College of London, London, England, U.K.
xiv Contributors
Peter W. Heald Department of Dermatology, West Haven VA Medical Center, Yale University
School of Medicine, New Haven, Connecticut, U.S.A.
Maria Teresa Hojyo-Tomoka Departamento de Dermatologia del Hospital General Dr. Manuel
Gea González, Tlalpan, Mexico City, Mexico
Brooke Jackson Skin and Wellness Center of Chicago, Chicago, Illinois, U.S.A.
Kenneth H. Kraemer Basic Research Laboratory, Center for Cancer Research, National Cancer
Institute, Bethesda, Maryland, U.S.A.
Henry W. Lim Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, U.S.A.
Harvey Lui Department of Dermatology and Skin Science, Vancouver Coastal Health Research
Institute, University of British Columbia, Vancouver, British Columbia, Canada.
Roy Palmer Photobiology Unit, St. John’s Institute of Dermatology, St. Thomas’ Hospital,
London, England, U.K.
Daniel B. Yarosh Applied Genetics Incorporated Dermatics, Freeport, New York, U.S.A.
Antony R. Young Division of Genetics and Molecular Medicine, St. John’s Institute of
Dermatology, King’s College London, London, England, U.K.
B Study on visible light was first published by Newton in 1672, and study
on action spectrum of ultraviolet light was published by Hausser and
Vahle in 1922.
T of imagination during history. This may explain why the Egyptians saw the Sun God Re
sailing the heaven in a boat and why the Greeks saw Apollo driving a chariot through the
sky. The Aztecs even offered beating human hearts to the Sun God, to give him enough
strength to reappear the next day. In nearly every civilization, people have adored the sun.
It was not only a question of religion but also of necessity. The sun is the universal source
of light and heat, and without the sun it would be dark and cold forever. This has nothing
to do with science. However, from early humankind on, people realized that the sun is extre-
mely important for life and it was, therefore, a topic of major concern. Stimulating people’s inter-
est is the beginning of science. Apart from this, there is also human experience. In many
civilizations, people realized that the sun could have a beneficial effect on certain diseases and
this, of course, had a stimulating effect on people’s imagination. It can take a very long time
before imagination evolves into a critical and structured approach, and in many cases this is a
step-by-step process.
The beginning of a real scientific interest in the solar spectrum dates from the 17th
century. One of the most important steps forward was the discovery of the visible spectrum
of the sun by Isaac Newton in England. He published the results of his experiments in 1672,
whereby the visible spectrum of the sun was fractionated by a prism into the different colors
of the rainbow (1). When Newton projected green plus red light on a wall, no green or red
light appeared, but only yellow light. When he added blue light, no green, red, or blue light
appeared, but only white light. To make white light, Newton did not need all colors, but
only red, green, and blue—the three basic colors.
In 1800, William Herschel, again in England, did some experiments with a thermometer to
evaluate which colors of the visible solar spectrum had the highest temperature. He noted that the
thermometer registered a higher temperature above the red visible light and, thus, discovered the
infrared spectrum of the sun (2).
The discovery of ultraviolet rays came a year later and can be attributed to the German
Johann Wilhelm Ritter. This discovery was partly based on previous experiments, by Carl
Wilhelm Scheele in Sweden, which had already been published in 1777 (3). Scheele could
show that paper strips dipped in a silver chloride solution became black after exposure to
the sun, because of a reduction of the silver, and that silver chloride did not become black in
the dark. Later on, this became the principle of analogous photography. Scheele could also
show that this was more pronounced with blue light than with red light. Ritter, a young scien-
tist, was convinced that invisible rays not only existed beyond the red end of the visible spec-
trum, as Herschel had demonstrated, but he also believed a similar invisible spectrum must
exist below the visible blue end of the spectrum. He first started his experiments with a ther-
mometer as Herschel did. Because he could not find a further decrease in temperature below
the visible blue as compared to the blue, he changed to Scheele’s method of using paper strips
dipped in silver chloride. He started measuring below the visible blue, where Scheele had
ended, and noted that the paper strips became even darker when exposed to invisible wave-
lengths shorter than the visible blue light. He, thus, discovered in 1801 the ultraviolet spectrum
of the sun, which he called “infraviolet” (4,5). Ritter died, unhappy, at the age of 33, without
ever realizing the importance of his discovery (6).
It took many years before the importance of ultraviolet rays became clear. After Ritter’s
death it was still a common belief that sunburn was due to heat damage. This changed with the
experiments of Everard Home in England in 1820 (7). Home wondered why the skin of black
people living in a hot climate was better protected than white skin, although black was absorb-
ing more heat. Therefore he exposed one of his own hands to the sun and covered the other one
with a black cloth. He developed sunburn on the exposed hand although a thermometer regis-
tered a higher temperature on the hand under the black cloth (8). Information at that time was
not so easily available as it is nowadays, which is illustrated by the fact that Moriz Kaposi, as
late as 1891, still believed that solar-induced erythema, and also pigmentation, were due to the
heat of the sun (9). Another illustration is the fact that Niels Finsen in Denmark, as late as 1900,
repeated Home’s experiment, independently, unaware of the previous experiment.
History of Human Photobiology 3
Although the damaging effects of ultraviolet radiation became gradually better known, it
took a few more years before real action-spectrum studies were undertaken. During Word War
I, Karl Hausser was the chief radiation physicist for Siemens AG in Germany. While working
near the battlefields, he got pulmonary tuberculosis and was sent to Davos in Switzerland for
heliotherapy. He took long walks in the mountains and noted that sunburn occurred easier at
noontime than in the afternoon hours (10). As a result, he and Vahle made the first detailed
action-spectrum studies for erythema and pigmentation of human skin. They could show
that erythema and pigmentation depend upon the wavelengths of the ultraviolet radiation
and that the effect is mainly due to wavelengths shorter than 320 nm (11). In 1922, they pub-
lished the action spectra for the induction of erythema and pigmentation in human skin
using a monochromator and an artificial mercury lamp.
During the Second International Congress on Light in 1932 in Copenhagen, Denmark,
William Coblentz proposed to divide the ultraviolet spectrum of the sun into three spectral
regions: UVA (315 –400 nm), UVB (280 – 315 nm), and UVC (,280 nm) (9).
Measuring the intensity of solar irradiation was another problem. Many different systems
were available (12). Although cadmium cathodes were already used in Potsdam in Germany
and in Davos in Switzerland as early as 1910, the first integrating analog meter was developed
by Rentschler in the mid-1930s, using a zirconium photodiode (11). However, these photo-
diodes showed great individual variability and temperature sensitivity. In addition, good
amplifiers were not available at that time. In the mid-1950s, Robertson developed a UVB
detector with a stable cold cathode thyratron to amplify the weak detector output (11). This
detector was later redesigned and became the popular Robertson-Berger meter.
PHOTODERMATOSES
Probably the first to describe a photodermatosis was Robert Willan in 1798. He called the
disease eczema solare (31). The same condition was again described in 1887 by Veiel. What
they called eczema solare was, most likely, what we currently consider as polymorphous or
polymorphic light eruption. The name polymorphous light eruption was first used by Rasch
in Copenhagen, in 1900 (8). The same condition had also been described as prurigo aestivalis,
by Jonathan Hutchinson in 1878 (32). In 1919, Haxthausen used the term polymorphous light
eruption as a collective name for eczema solare and prurigo aestivalis, because it was not pos-
sible to differentiate between the two conditions (33).
Hydroa vacciniforme was first described by Bazin in 1860 (8). Later on, this term became
more confusing because it was not only used to describe hydroa vacciniforme, as it is known
currently. Some authors used the same terminology to describe what is, presently, called con-
genital erythropoietic porphyria.
Moriz Kaposi was the first to describe xeroderma pigmentosum in 1870 (8), but he did not
make the relationship with solar exposure or light, which was only done many years later by
Paul Unna (24).
The symptoms of congenital erythropoietic porphyria have been described under differ-
ent names such as pemphigus leprosus by Schultz in 1874 (34), xeroderma pigmentosum by
Gagey in 1896 (35), hydroa vacciniforme by M’Call Anderson in 1898 (36), hereditary syphilis
by Vollmer in 1903 (37), hydroa aestivale by Ehrmann in 1905 (38) and Linser in 1906 (39), until
Günther described the condition, in 1911, as a porphyria (40). One of the first symptoms of this
disease is the dark coloration of the urine, which was already noticed in the first description by
Schultz in 1874 (34), whereas M’Call Anderson was the first to recognize in his description of
1898 that the disease was caused by light (36). That the lesions resulted from the sensitization of
the skin to light exposure by porphyrins, was first suggested by Ehrmann, in 1909 (41). The
History of Human Photobiology 5
name Günther’s disease, to describe congenital erythropoietic porphyria, dates from a later
period. Even in 1926, Rasch still proposed to call the disease M’Call Anderson’s disease (8).
The same year the same author published a case report of a patient with porphyrinuria
and blisters on the back of both hands (8). Rasch did not make use of the terminology por-
phyria cutanea tarda, till that time, but he clearly made the link with alcoholism. The name
porphyria cutanea tarda was first used in 1937 by Waldenström, who also extensively
studied acute intermittent porphyria (42). The other porphyrias were described later, even
after World War II.
While the previous photodermatoses have mainly been described for the first time in the
19th century, solar urticaria has been described at the beginning of the 20th century. Probably
the first report of the induction of urticaria by sunlight is the one reported by Merklen, in 1904
(43). He was the first to consider urticaria, caused by light, to be a distinct clinical entity. A year
later in 1905, Ward, for the first time, provoked urticaria by means of sun exposure under con-
trolled conditions (44). The name “solar urticaria” was suggested by Duke in 1923 (45), and in
1928, Wucherpfennig could quantify the urticarial response by phototesting with increasing
doses of different wavelengths (46). In 1942, Rajka reported the passive transfer to normal
volunteers by an intradermal injection of serum from a person with solar urticaria (47).
The history of topically or systemically-induced photosensibilization starts earlier.
The first reports of systemically-induced photosensibilization were mainly due to occasional
intake of plant extracts. Already, in the 16th century, skin reactions have been observed in
animals after eating buckwheat followed by sun exposure (48). Similar observations have
been made in the 18th century in Sicily and in Napels in Italy, where white sheep showed
severe skin reactions after eating Hypericum, while the black sheep did not (49).
Between 1908 and 1910 Hausmann discovered that hematoporphyrin can photosensitize
animal skin and that the responsible wavelengths are in the green visible light around 500 nm
(50). The first clinical proof that some substances can photosensitize human skin in combination
with sun exposure dates from 1912, when our colleague Meyer-Betz injected himself with hema-
toporphyrin and exposed himself to the sun (51). By doing this he could demonstrate that the
combination of a photosensitizing substance and sun exposure can induce a skin reaction that
each of these two components separately would not induce, which is the definition of a photo-
sensibilization. Another example of a systemic photosensibilization in human skin is the “eosin
disease,” which was seen in patients treated with oral eosin for epilepsy or for other reasons (50).
In 1939, Stephen Epstein could demonstrate in human volunteers, using sulfanilamide as
the photosensitizer, that two mechanisms are involved: a dose-dependent phototoxic reaction
and a nondose-dependent photoallergic reaction (52).
It was first reported in 1913 by Louis Lewin, that topically applied agents can photosen-
sitize in workers using coal tar pitch (53). In 1916, Emanuel Freund reported phototoxic reac-
tions to eau de cologne, which was the first description of a berloque dermatitis, and he
concluded that oil of bergamot was most probably the photosensitizing substance (54). The
first description of a phytophotodermatitis dates from 1920 by Moritz Oppenheim (55). Hans
Kuske could show that the photosensitizing substances in these plants were furocoumarins,
and that their action spectrum was mainly between 334 and 366 nm, which was the first deter-
mination of an action spectrum for the furocoumarins (56). The photopatch test was introduced
in 1941 by Burckhardt (57).
PHOTOPROTECTION
It has always been part of human nature to protect the skin against sunburn by avoiding sun
exposure or by wearing appropriate clothes. During history, many substances have probably
been tried out as photoprotectors. As far as we know, the first scientific reports date from
the end of the 19th century. In 1878, Veiel reported the use of tannin as a photoprotector, but
its use was limited because of its staining potential (58). In 1891, Friedrich Hammer of
Germany even published a monograph, probably the first large monograph on photobiology,
discussing photoprotection and experimenting with different topical agents, to prevent
sunburn (9,59).
6 Roelandts
When Hausser and Vahle, in 1922, reported that sunburn in human skin is caused by a
specific part of ultraviolet spectrum between 280 and 315 nm (60), one realized that the skin
could be protected by filtering out these specific wavelengths. This resulted in a growing inter-
est in sunscreen agents. The first commercially available sunscreen appeared on the market in
1928, in the United States, as an emulsion containing benzyl salicylate and benzyl cinnamate
(61). During the subsequent years, sunscreens were not widely available and were not used
on a large scale. In Germany the first commercial sunscreen became available in 1933 (62)
and in France, in 1936 (63). The German product was an ointment. The French one was an
oil preparation and became a great success, because it was launched the same year that paid
holidays were granted.
During World War II, there was a real need for good sun protection for soldiers engaged
in tropical warfare. One of the most practical and effective agents for sun protection turned out
to be Red veterinary petrolatum, and was used as standard equipment (64). After the war,
styles were changing in many countries and a number of filters were synthesized, tested,
and marketed. In many cases these were less effective oil preparations, apparently with the
sole purpose of promoting tanning. During the 1970s, holiday travel to sunny areas steadily
became more popular, resulting in an increasing demand for sunscreens with better and
broader protection. This became possible by incorporating UVB filters into milks and creams
instead of oils. In 1979, real UVA filters became available and a further advance was the intro-
duction of micronized inorganic powders such as titanium dioxide since 1989, and zinc oxide
since 1992 (65).
With the increasing use of sunscreens, there was also an increasing need to find a good
method to evaluate their protection. In the early years, the usual way was to determine the
absorption spectrum of the sunscreen. In 1934, Friedrich Ellinger in Berlin proposed to use a bio-
logical method by determining the MED in protected and unprotected skin, using both forearms
and a mercury lamp (66). He concluded that the method of choice was the way in which the MED
could be decreased. He was right, but the right irradiation source was not yet used. In 1956,
Rudolf Schulze in Germany proposed to test commercially available sunscreens by giving
them a protection factor (67). The idea was to divide the exposure time needed to induce erythema
with sunscreen by the exposure time needed without sunscreen. He used a series of Osram-Ultra-
Vitalux lamps to apply a series of increasing ultraviolet doses (40% increases), in both protected
and unprotected skin. The light source he used was more similar to the solar spectrum than the
light source used by Ellinger. The method was further improved in 1974 in Austria by Franz
Greiter, who developed the concept of the sun protection factor (SPF) (68). In 1978, this method
was adopted by the Food and Drug Administration (FDA), in the United States (69) and
became internationally accepted. At that time sunscreens were mainly used to prolong the
exposure time in order to tan, and at the same time to avoid sunburn.
used filtered sunlight in the treatment of lupus vulgaris. At a time when no antibiotics or anti-
inflammatory agents were available, Finsen’s phototherapy was more than welcome. Because a
treatment session with filtered natural sunlight could take several hours, and because natural
sunlight was not always available in Denmark, Finsen became logically interested in more
powerful artificial irradiation sources. In 1894, Heinrich Lahmann in Germany was probably
the first to use an artificial light source in the treatment of skin diseases (70), although he
was not the first to construct such a lamp. The first to make a (mercury) lamp was, probably,
Way around 1856 to 1860 (12).
In April 1896, Finsen founded the “Lysinstitut” or Medical Light Institute (later Finsen
Institute), in Copenhagen, where he continued to use filtered natural sunlight; but from 1897
onward he also used a new carbon arc lamp in combination with quartz filters (73).
Around the same time, in 1898, Willibald Gebhardt published what is probably the first
book on phototherapy, Die Heilkraft des Lichtes (74). A major problem when using a carbon
arc lamp to irradiate human skin was the high temperature. Finsen et al. developed a water-
cooling system and an irradiation unit where four patients were irradiated at the same time.
This irradiation source became internationally known as the Finsen lamp. After Finsen in
1901 published his therapeutic results with lupus vulgaris, treated by concentrated UV
doses from a carbon arc lamp, he received the Nobel Prize for Medicine in 1903, the only
Nobel Prize ever to be awarded for dermatology (73). From this time on the Finsen lamp
was used in all major dermatology departments inside and also outside Europe in the treat-
ment of lupus vulgaris. Finsen also wrote the foreword in the first French textbook on photo-
therapy, Photothérapie et Photobiologie, written by Leredde and Pautrier and published in 1903
(75). In 1904, a smaller lamp was constructed by Finsen and Reyn, the Finsen-Reyn lamp,
which allowed therapist to irradiate one single patient and which was more convenient in
smaller treatment centers. All these lamps were used only for localized irradiations. In the
same year, 1904, the Schott Company in Jena, Germany, was able to construct an ultraviolet
tube (9), using the low-pressure mercury lamp developed by the American Peter Hewitt in
1902 (76), and using a new type of glass containing barium sulfate.
About the same time, the first experiments started with the use of photosensitizers and
visible light in the treatment of skin cancer that became the principle of photodynamic
therapy, nearly a century later. During the winter of 1897 and 1898, Oscar Raab, in Munich,
had already noticed that the death of the paramecia, which he was studying, not only
depended upon the concentration of the dye acridine but also on the intensity of the light
in the laboratory (77). In 1905, Albert Jesionek and Hermann von Tappeiner could cure
three out of five basal cell carcinomas they had treated with intralesional eosin and light
exposure (78).
A lot of research was done in the construction of new phototherapy equipment. In
1906, Hans Axmann in Germany constructed a horizontal treatment cabin equipped with
a series of low-pressure mercury tubes, allowing total body irradiations (9,79). Unfortunately,
the output of these lamps was not high enough to obtain a sufficient therapeutic effect in
lupus vulgaris and, therefore, could not compete with the Finsen-Reyn lamp. In 1906 also,
Richard Küch in Hanau, Germany, made the first quartz lamp. By using quartz instead of
lead glass, he was able to develop a high-pressure mercury lamp with a higher output
(80). In the beginning these lamps were only used to illuminate streets and warehouses,
where they gradually replaced the carbon arc lamps, which had a lower output and
higher running costs (9). Soon after, the high-pressure mercury lamp was also used for thera-
peutic purposes, because of the same reasons. In 1908, Carl Franz Nagelschmidt made a table
model of the high-pressure mercury lamp for total body irradiation, but this was nothing
more than a prototype. After Hugo Bach constructed his own quartz lamp in 1911, this
“Höhensonne” lamp was modified many times and was used for almost 50 years for total
body irradiations (9). When in 1912 Ernst Kromayer in Berlin made a quartz lamp with a
high UV output, and improved the lamp by using a water cooling system, it became possible
to treat different skin diseases (81,82). Kromayer commercialized his lamp in 1906, and it
became one of the most popular treatment lamps in dermatology for decades. It was not
only used in Europe but also in Asia and the United States, although it could only be
used for localized irradiations.
8 Roelandts
In 1919, the pediatrician Kurt Huldschinsky published his therapeutic results with high-
pressure mercury lamps in the treatment of rachitis (83). This again was a very interesting
indication for the use of phototherapy in medicine. Its success was greatly due to the use of
the new radiography technique as a way to control the evolution of the disease.
Lupus vulgaris was not the only indication for the use of phototherapy in dermatology.
William Henry Goeckerman, in the United States, started testing different photosensitizers in
the treatment of psoriasis in order to improve the therapeutic effect of the sun. In 1925, he
published his results using coal tar in combination with ultraviolet exposure from a high-
pressure mercury lamp (84). This treatment became very popular worldwide and was used
for decades to treat psoriasis. Later on, John Ingram in the United Kingdom combined this
treatment with dithranol (85).
In 1927, Erich Uhlmann could induce repigmentation in vitiligo patients combining
bergamot oil and exposure to natural sunlight or to a Kromayer lamp (86).
In 1947, a new type of lamp was born, the high-pressure xenon lamp. In contrast to the
high-pressure mercury lamp, this lamp had a continuous spectrum ranging from the ultra-
violet to the infrared spectrum, similar to the natural solar spectrum. Because this lamp was
more costly to use it did not become popular for therapeutic purposes but was only used for
research and phototesting.
In 1958, the use of blue light phototherapy (420 – 480 nm) was reported for the treatment
of newborns with jaundice, after a nurse noticed that the yellow pigmentation in jaundiced
babies faded away after sun exposure (87). Apart from its use in pediatrics to treat jaundice
in newborns, heliotherapy and phototherapy were done on an organized scale to treat tubercu-
losis, leg ulcers, and skin diseases.
was not the case with the use of phototherapy in the treatment of skin disorders. During history
and up to the present, several skin disorders have been treated with heliotherapy or
phototherapy.
Before the end of the 19th century its use was more anecdotal. Probably the first report of
the use of sunlight in the treatment of skin disorders dates from about 1400 BC , when plant
extracts followed by sun exposure to treat vitiligo was used in India (93). The same treatment
was also used in ancient Egypt. The anecdotal use of heliotherapy during the centuries changed
at the end of the 19th century with Niels Finsen. He was the first to use sun exposure in a more
standardized way on a large scale for a specific indication, with a detailed account of its thera-
peutic results. He was also the first to switch from heliotherapy with natural sunlight to photo-
therapy with artificial lamps, making it more practical. The Nobel Prize he won in 1903 had a
booster effect on phototherapy. Probably a similar effect happened at the end of the last century
with the development of phototherapeutic UVA (PUVA) treatment or photochemotherapy.
Photochemotherapy has a long history (94). It started with the use of plant extracts
and sun exposure to treat vitiligo and resulted in the use of oral 8-methoxypsoralen
(8-MOP) and total body UVA-irradiation cabins to treat psoriasis. Many different steps
have been involved. The first step was the use of certain plant extracts to treat vitiligo
(95). The next step was the isolation of the active ingredients in these plants as 8-MOP
and 5-methoxypsoralen (5-MOP), in 1947, and the first trials with 8-MOP and sun exposure
in vitiligo patients (96 –99). Later, the action-spectrum studies were introduced (100,101).
These were followed by the topical use of 8-MOP in combination with UV irradiation to
treat psoriasis (102) and in 1967 by the oral use of 8-MOP to treat psoriasis (103). The
next step was the use of “blacklight” UVA tubes in combination with topical 8-MOP in
the treatment of vitiligo (104). One year later, in 1970, Mortazawi used the same type of
UVA tubes in a total body irradiation cabin, using topical 8-MOP to treat psoriasis
(105,106). The use of UVA tubes in a total body irradiation cabin was new. Although
the UVA output of these tubes was effective when the 8-MOP was used topically, it was
insufficient when administered orally. In 1974, Parrish et al. reported the use of a new
type of a high-intensity UVA tube in combination with oral 8-MOP in the treatment of psor-
iasis (107). This approach was more effective and was the real start of PUVA therapy, which
revolutionized dermatological treatment.
The history of UVB phototherapy is not as old as the history of photochemotherapy, and
was started at the end of the 19th century with the work of Niels Finsen on lupus vulgaris. In
1923, Alderson recommended the use of a mercury quartz lamp to treat psoriasis. In 1925,
Goeckerman associated tar with UV irradiations in the treatment of psoriasis, and this
remained for about half a century as the most popular form of phototherapy in dermatology
(84). The main drawback of this treatment was the low output of the lamps. In 1958,
Zimmerman in the United States described an irradiation cabin, using fluorescent UVB
tubes (108). Later, several other total body irradiation sources were described (109,110). After
a successful start of PUVA treatment, Wiskemann suggested, in 1978, using an irradiation
cabin with broadband UVB tubes (111). During the subsequent years, broadband UVB photo-
therapy became an alternative for PUVA treatment. Because broadband UVB phototherapy
was less efficient for psoriasis than PUVA therapy, it never achieved its popularity.
This changed in 1988 when narrowband UVB phototherapy was introduced in the treatment
of psoriasis by van Weelden et al. (112) and Green et al. (113). This was more efficient than
broadband UVB phototherapy.
In the meantime, other types of phototherapy have been developed such as extracorpo-
real photopheresis for cutaneous T-cell lymphoma (114), high-dose UVA1 phototherapy for
atopic dermatitis and localized scleroderma (115), and topical photodynamic therapy with
visible light for actinic keratoses and superficial basal cell carcinoma (116).
and German. The journal appeared from 1900 until 1904, when Finsen died. In 1912, Hans
Meyer in Germany started the new journal Strahlentherapie, dealing not only with phototherapy
but also with radiotherapy. Because phototherapy became less important after World War II,
this journal is no longer a photobiological or photodermatological journal.
In 1927, the Deutsche Gesellschaft für Lichtforschung (German Society for Research on
Light) was founded (9). The first president was Hans Meyer, editor of the journal Strahlenther-
apie. One year later, in 1928, the first international society was founded by a group of French
colleagues, called Comité International de la Lumière, with Axel Reyn as the first president. Reyn
was Danish and a pupil of Finsen. The First International Congress on Light was held in 1929
in Paris, France, with Jean Saidman as its president. The second congress was in Copenhagen,
Denmark, in 1932 and the third one took place in Wiesbaden, Germany, in 1936. In 1937, the
decision was made to attribute a prize—the Finsen medal—during each congress to an out-
standing cutaneous photobiologist. The next congress was again held in Paris, France, in
1951. At that time, the name of the society became the Comité International de Photobiologie
and the name of the congress changed to the “International Congress on Photobiology” (9).
In 1962, Douglas McLaren started the first journal in English, named “Photochemistry
and Photobiology: An International Journal.” The American Society of Photobiology was
founded in 1972 (11) and the Japanese Society for Photomedicine and Photobiology in 1978.
In 1984, Christer Jansén from Finland and Göran Wennersten from Sweden started another
international journal in English, named “Photodermatology clinical and experimental,” the
name (and size) of which changed in 1990 to “Photodermatology, Photoimmunology & Photo-
medicine.” The Photomedicine Society in the United States was founded in 1991 and the Euro-
pean Society for Photodermatology in 1999.
In 2004, another journal was launched, named “Photodiagnosis and Photodynamic
Therapy.” Apart from these journals several other journals are available dealing only partly
with cutaneous photobiology and photomedicine, such as the “Journal of Photochemistry and
Photobiology. B: Biology,” which started in 1987 as part of the “Journal of Photochemistry.”
REFERENCES
1. Newton I. New theory about light and colours. Philosophical transactions 1672; I:3075– 3087.
2. Herschel W. Investigation of the powers of the prismatic colours to heat and illuminate objects.
Philos Trans R Soc Lond 1800; I:255 –283.
3. Scheele CW. Chemische Abhandlung von der Luft und dem Feuer. Upsala, Leipzig: Swederus,
Crusius, 1777.
4. Ritter JW. Physisch-chemische Abhandlungen in chronologischer Folge. Band II. Leipzig 1806;
81 – 107.
5. Ritter JW. Entdeckungen zur Elektrochemie, Bioelektrochemie und Photochemie. Ostwalds
Klassiker der exakten Wissenschaften. Band 271. Leipzig: Akademische Verlagsgesellschaft
Geest & Portig K.-G., 1986.
6. Roelandts R. Bicentenary of the discovery of the ultraviolet rays. Photochem Photoimmunol
Photomed 2002; 18:208.
7. Home E. On the black rete mucosum of the Negro, being a defense against the scorching effect of the
sun’s rays. Philos Trans R Soc London 1820; 111:1.
8. Rasch C. Some historical and clinical remarks on the effect of light on the skin and skin diseases. Proc
R Soc Med 1926; 20:11 – 20.
9. Lentner A. Geschichte der Lichttherapie. Aachen: Foto-Druck Mainz, 1992.
10. Hausser KW, Vahle W. Sonnenbrand und Sonnenbräunung. Wiss Veröff Siemens-Konzern 1927;
6:101.
History of Human Photobiology 11
11. Urbach F, Forbes PD, Davies RE, Berger D. Cutaneous photobiology: past, present, and future.
J Invest Dermatol 1976; 67:209– 224.
12. Saidman J. Les rayons ultra-violets en thérapeutique. Paris: Gaston Doin & Cie, 1928.
13. Ebermaier JC. Versuch einer Geschichte des Lichtes in Rücksicht seines Einflusses auf die gesamte
Natur, und auf den menschlichen Körper, ausser dem Gesichte, besonders. Osnabrück: Karl und
Comp, 1799.
14. Charcot P. Erythème produit par l’action de la lumière électrique. C R Soc Biol (Paris) 1858; 5:
63 – 65.
15. Downes AH, Blunt TP. Researches on the effect of light upon bacteria and other organisms. Proc R
Soc Lond 1877; 26:488– 500.
16. Heinrich P. Von der Natur und den Eigenschaften des Lichts. St. Petersburg: Veröffentl d kaiserli-
chen Akademie der Wissenschaften, 1808.
17. Unna PG. Uber das Pigment der menschlichen Haut nebst einem Vorschlag für wanderlustige
Kollegen. Med prakt Derm 1885; 4:277 – 294.
18. Widmark EJ. Ueber den Einfluss des Lichtes auf die Haut. Hygiea Festband 1889; 3:1– 23.
19. Bloch B. Das Problem der Pigmentbildung in der Haut. Arch f Derm u Syph 1917; 124:129– 208.
20. Riehl. Uber eine eigenartige Melanose. Wien klin Wochenschr 1917; 780.
21. Möller M. Der Einfluss des Lichtes auf die Haut in gesundem und krankhaften Haut. Stuttgart:
Nägele, 1900.
22. Miescher G. Die Schutzfunktionen der Haut gegenüber Lichtstrahlen. Strahlentherapie 1931; 39:
601 – 618.
23. Bowles RL. On the influence of solar rays on the skin. Br J Dermatol 1893; 237.
24. Unna PG. Die Histopathologie der Hautkrankheiten. Berlin: Hirschwald, 1894.
25. Dubreuilh W. Des hyperkeratoses circonscrites. Ann Derm Syph 1896; 7:1158 – 1204.
26. Dubreuilh W. Epithéliomatose d’origine solaire. Annales de Derm et Syph 1907; 387.
27. Jadassohn. Cutis rhomboidalis nuchä mit colloider Degeneration. Zentr f Haut u Geschlechtskrankh
1925; XVII :272.
28. Findlay GM. Ultraviolet light and skin cancer. Lancet 1928; 2:1070– 1073.
29. Roffo AH. Uber die physikalische Aetiologie der Krebskrankheit mit besonderer Betonung des
Zusammenhangs mit Sonnenbestrahlungen. Strahlentherapie 1939; 66:328– 350.
30. Blum HF, Kirkby-Smith S, Grady HG. Quantitative induction of tumors in mice with ultraviolet
radiation. J Natl Cancer Inst 1941; 2:259– 268.
31. Willan R. On cutaneous diseases. London: Johnson, 1808.
32. Hutchinson J. Lectures on clinical surgery. Vol 1. London: Churchill, 1878.
33. Brodthagen H. Polymorphous light eruption. In: Urbach F, ed. The Biological Effects of Ultraviolet
Radiation. New York: Pergamon Press 1969:479– 486.
34. Schultz JH. Ein Fall von Pemphigus leprosus, kompliciert durch Lepra visceralis. Inaug. Diss.
Greisswald, 1874.
35. Gagey. Cas d’hémoglobinurie au cours d’un xeroderma pigmentosum. Thèse de Paris, 1896.
36. M’Call Anderson T. Hydroa vacciniforme. Br J Dermatol 1898; 1.
37. Vollmer. Uber hereditäre Syphilis und Hämatoporphyrinuria. Archiv f Derm u Syph 1903; 1XV:221.
38. Ehrmann. Hydroa aestivale. Arch f Derm u Syph 1905; 1XXVII :163.
39. Linser. Hydroa aestivale und Hämatoporphyrinuria. Archiv f Derm u Syph 1906; 1XXIX :251.
40. Günther. Die Hämatoporphyrie. Dtsch Arch f klin Med 1911; 105:89– 146.
41. Ehrmann S. Weitere Untersuchungen über Lichtwirkung bei Hydroa aestivalis (Bazin), Summer-
eruption (nach Hutchinson). Arch f Derm u Syph 1909; 97:75 – 86.
42. Waldenström J. Studien über porphyrie. Acta Med Scand 1937; suppl. 82:133.
43. Merklen P. Urticaria. In: Besnier E, Brocq L, Jacquet L, eds. La Pratique Dermatologique: Trait de
Dermatologie Appliquée. Paris: Masson et Cie, 1904:728– 771.
44. Ward SB. Erythema and urticaria with a condition resembling angioneurotic edema caused by
exposure to sun’s rays. NY Med J 1905; 81:742– 743.
45. Duke WW. Urticaria caused by light. JAMA 1923; 80:1835– 1838.
46. Wucherpfennig V. Pathologische Lichtüberempfindlichkeit in qualitativer und quantitativer
Hinsicht, nebst Untersuchungen zur Pathogenese der Lichtquaddel. Arch Dermatol Syph (Berl.)
1928; 156:520– 544.
47. Rajka E. Passive transfer in light urticaria. J Allergy Clin Immunol 1942; 13:327– 345.
48. Merian L. Experimentelle Beiträge zur Buchweizenerkrankung (Fagopyrismus) der Tiere. Arch
Anat Physiol, Physiol Abt 1915; 161:188.
49. Barth J. Historische und aktuelle Aspekte der Fotosensibilisierung. Derm Mschr 1976; 162: 961 – 973.
50. Lipschitz W. Im Blut kreisende Substanzen als Grundlage für Lichtdermatosen. Strahlentherapie
1928; 29:9– 19.
51. Meyer-Betz F. Untersuchungen über die biologische (photodynamische) Wirkung des Hämatopor-
phyrins und anderer Derivate des Blut- und Gallenfarbstoffs. Dtsch Arch klin Med 1913;
112:476– 503.
12 Roelandts
52. Epstein S. Photoallergy and primary photosensitivity to sulfanilamide. J invest Derm 1939; 2:43– 51.
53. Lewin L. Uber die photodynamische Wirkungen von Inhaltsstoffen des Steinkohlenteerpechs am
Menschen. Münch Med Wochenschr 1913; 60:1529– 1530.
54. Freund E. Uber bisher noch nicht beschreibende künstliche Hautverfärbungen. Dermatol
Wochenschr 1916; 63:931.
55. Oppenheim M, Fessler A. Über eine streifenförmige bullöse Dermatitis (Freibad- und Wiesenderma-
titis). Derm Wschr 1928; 86:183– 187.
56. Kuske H. Perkutane Photosensibilisierung durch pflanzliche Wirkstoffe. Dermatologica 1940; 82:
274 – 338.
57. Burckhardt W. Untersuchungen über die Photoaktivität einiger Sulfanilamide. Dermatologica 1941;
83:63– 68.
58. Henschke U. Untersuchungen an Lichtschutzmitteln. Strahlentherapie 1940; 67:639– 668.
59. Hammer F. Uber den Einfluss des Lichtes auf die Haut. Stuttgart: F. Enke, 1891.
60. Hausser KW, Vahle W. Die Abhängigkeit des Lichterythems und der Pigmentbildung von der
Schwingungszahl (Wellenlänge) der erregenden Strahlung. Strahlentherapie 1922; 13:47– 71.
61. Jass HE. Cosmetic suntan products. Cutis 1979; 23:554 – 561.
62. Finkel P. Lichtschutzmittel. In: Umbach W, ed. Kosmetik. Stuttgart, New York: Georg Thieme Verlag,
1995:147– 163.
63. Rebut D. The sunscreen industry in Europe: past, present and future. In: Lowe NJ, Shaath NA, eds.
Sunscreens, Development, Evaluation, and Regulatory Aspects. New York: Marcel Dekker, Inc,
1990:161– 171.
64. MacEachern WN, Jillson OF. A practical sunscreen “Red Vet Pet.” Arch Dermatol 1946; 89:147 –150.
65. Roelandts R. Advances in sunscreen technology: choosing the sunscreen to suit. Current Opinion in
Dermatology 1995:173– 177.
66. Ellinger F. Zur Frage der Wertbestimmung von Lichtschutzmitteln. Arch exp Path u Pharmakologie
1934; 175:481– 488.
67. Schulze R. Einige Versuche und Bemerkungen zum Problem der handelsüblichen Lichtschutzmittel.
Parf u Kosmet 1956; 37:310– 315.
68. Greiter F. Sonnenschutzfaktor – Entstehung, Methodik. Parf u Kosmet 1974; 55:70 – 75.
69. Dept of Health, Education and Welfare, Food and Drug Administration. Sunscreen drug products
for over-the-counter human use. Federal Register, August 25 1978; 43:38206– 38269.
70. Barth J, Köhler U. Photodermatologie in Dresden-ein historischer Abriss. Festschrift anlässlich des
75. Geburtstages von Prof. Dr. h.c. H.-E. Kleine-Natrop (1917 – 1985). Dresden 1992.
71. From a special correspondent. Royal Victoria Hospital, Netley. Br Med J 1966; 5484:412– 413.
72. Palm TA. The geographical distribution and aetiology of rickets. The Practitioner October and
November 1890.
73. Roelandts R. A new light on Niels Finsen, a century after his nobel prize. Photodermatol Photoim-
munol Photomed 2005; 21:115 – 117.
74. Meffert H, Bahr T. Willibald Gebhardt (1861– 1921). Sein Leben und seine Verdienste um die
Photomedizin. Dermatol Monatsschr 1989; 175:699 –705.
75. Leredde, Pautrier. Photothérapie et Photobiologie. Paris: Naud, 1903.
76. Heusner HL. Zum zehnjährigen Jubiläum der medizinischen Quarzlampe. Strahlentherapie 1916;
7:628– 638.
77. Raab O. Untersuchungen über die Wirkung fluorezierende Stoffe. Z Biol 1899; 39:16.
78. Jesionek A, Tappeiner HV. Zur Behandlung der Hautcarcinome mit fluorescierenden Stoffen. Dtsch
Arch Klin Med 1905; 82:223– 227.
79. Axmann H. Weitere Erfahrungen über die Uviolbehandlung, sowie einen neuen Apparat zur
Bestrahlung des ganzen Körpers mittels ultravioletten Lichtes (Uviolbad). Dtsch Med Wochenschr
1906; 32:583– 584.
80. Küch R, Retschinsky T. Photometrische und spektralphotometrische Messungen am Quecksilberbo-
gen bei hohem Dampfdruck. Ann Physik 1906; 20:563– 583.
81. Kromayer E. Quecksilber-Wasserlampen zur Behandlung von Haut und Schleimhaut. Dtsch med
Wochenschr 1906; 32:377– 380.
82. Rollier A. Heliotherapy. Oxford: Oxford Medical Publications, 1923.
83. Huldschinsky K. Heilung von Rachitis durch künstliche Höhensonne. Dtsch med Wochenschr 1919;
45:712– 713.
84. Goeckerman WH. Treatment of psoriasis. Northwest Med 1925; 24:229– 231.
85. Ingram JT. The approach to psoriasis. Br Med J 1953; II:591– 594.
86. Uhlmann E. Pigmentbildung bei Vitiligo. Med Klin 1927; 23:279– 280.
87. Cremer RJ, Perryman PW, Richards DH. Influence of light on the hyperbilirubinaemia of infants.
Lancet 1958; I:1094– 1097.
88. Saleeby CW. Sunlight and Health. London: Nisbet & Co:1923– 1926.
89. Bernhard O. Light treatment in surgery. London: Edward Arnold & Co, 1926.
History of Human Photobiology 13
90. Bernhard O. Über offene Wundbehandlung durch Insolation und Eintrocknung. Münch med
Wochenschr 1904:Nr 1.
91. Haeberlin. Zur Behandlung granulierender Wunden. Münch med Wochenschr 1907:Nr 8.
92. Dosquet W. Offene Wundbehandlung und Freiluftbehandlung. Leipzig: Georg Thieme, 1916.
93. Fitzpatrick TB, Pathak MA. Historical aspects of methoxsalen and other furocoumarins. J Invest
Dermatol 1959; 31:229– 331.
94. Roelandts R. The history of photochemotherapy. Photodermatol Photoimmunol Photomed 1991;
8:184– 189.
95. Marquis L. Arabian contributors to Dermatology. Int J Dermatol 1985; 24:60 – 64.
96. Fahmy IR, Abu-Shady H. Ammi majus Linn: pharmacognostical study and isolation of a crystalline
constituent, ammoidin. Q J Pharmacol 1947; 20:281– 291.
97. Fahmy IR, Abu-Shady H, Schönberg A, et al. A crystalline principle from Ammi majus L. Nature
1947; 160:468– 469.
98. Fahmy IR, Abu-Shady H. Ammi majus Linn: the isolation and properties of ammoidin, ammidin
and majudin, and their effect in the treatment of leukoderma. Q J Pharmacol 1948; 21:499– 503.
99. El-Mofty AM. A preliminary clinical report on the treatment of leukoderma with Ammi majus Linn.
J Egypt Med Assoc 1948; 31:651– 665.
100. Buck HW, Magnus IA, Porter AD. The action spectrum of 8-methoxypsoralen for erythema in
human skin. Br J Dermatol 1960; 72:249– 255.
101. Pathak MA, Fellman JH. Activating and fluorescent wavelengths of furocoumarins: psoralens.
Nature 1960; 185:382– 383.
102. Allyn B. Studies on phototoxicity in man and laboratory animals. Paper presented at the Twenty-
First Annual Meeting of the American Academy of Dermatology. Chicago, December 1962.
103. Oddoze L, Témime P, Marchand JP, et al. L’association “meladinine” per os et rayons U.V. dans le
traitement du psoriasis. Bull Soc Fr Dermatol Syph 1967; 74:609– 610.
104. Fulton JE, Leyden J, Papa C. Treatment of vitiligo with topical methoxsalen and blacklite. Arch
Dermatol 1969; 100:224– 229.
105. Mortazawi SMA. Meladinine und UVA bei Vitiligo, Psoriasis, Parapsoriasis und Akne vulgaris.
Dermatol Monatsschr 1972; 158:908– 909.
106. Mortazawi SMA, Oberste-Lehn H. Lichtsensibilisatoren und ihre therapeutischen Fähigkeiten.
Z Haut-Geschl Kr 1973; 48:1– 9.
107. Parrish JA, Fitzpatrick TB, Tanenbaum L, et al. Photochemotherapy of psoriasis with oral methox-
salen and longwave ultraviolet light. N Engl J Med 1974; 291:1207– 1211.
108. Zimmerman MC. Ultraviolet light therapy. Arch Dermatol 1958; 78:646– 652.
109. Wiskemann A. Die neuere Entwicklung der Lichttherapie. Dermatol Wochenschr 1963; 147:377– 383.
110. Forck G. Ganzkörperbestrahlung mit UV-Licht. Aufbau einer neuartigen Anlage. Dermatol
Wochenschr 1964; 150:290– 294.
111. Wiskemann A. UVB-Phototherapie der Psoriasis mit einer fur die PUVA-Therapie entwickelten
Stehbox. Z Hautkr 1978; 53:633– 636.
112. van Weelden H, De La Faille HB, Young E, et al. A new development in UVB phototherapy of
psoriasis. Br J Dermatol 1988; 119:11 – 19.
113. Green C, Ferguson J, Lakshmipathi T, et al. 311 nm UVB phototherapy—an effective treatment for
psoriasis. Br J Dermatol 1988; 119:691– 696.
114. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal
photochemotherapy. Preliminary results. N Engl J Med 1987; 316:297– 303.
115. Krutmann J, Schopf E. High-dose-UVA1 phototherapy: a novel and highly effective approach for the
treatment of acute exacerbation of atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1992;
176:120– 122.
116. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for
photodynamic therapy. J Photochem Photobiol B Biol 1992; 14:275– 292.
Another random document with
no related content on Scribd:
visited the mission school of Dr. Happer, located at the port, and also
went up to Canton to visit the hospital conducted by Dr. Parker, who
had been a lecturer in the University of Pennsylvania when he was a
student there. On Feb. 7, the party for Siam took passage on the
John Bagshaw, Captain Dare. After a call at Hong Kong they had a
quiet passage southward through the China Sea, and on the 23rd
reached Singapore, the maritime capital of the South China Sea.
Here they were fortunate in finding in the harbour the native-built
trading vessel Lion, Captain Dupont, owned by the King of Siam.
Although the ship was modeled after western vessels, it was of the
rudest native workmanship, without conveniences for occidental
travellers; and even the orientals who took passage had only deck
space allotted to them. For these three Westerners one small cabin
was made available and had to serve them day and night for the
twenty-four day voyage, a sail cloth being suspended in the middle
as a concession to foreign ideas of privacy. Provisions had to be
secured at Singapore and the Chinese cook of the vessel paid to
prepare them.
The passage from the South China Sea into the Gulf of Siam
proved to be the climax of the whole trip. A violent and prolonged
storm was encountered which not only added greatly to the misery of
the ship’s company but imperiled their lives:
“For nearly three days,” writes Dr. House, “we have not
had one cheering glimpse of the sun. Squall after squall of
rain has burst in its fury upon us; indeed it has been
almost one incessant rain, and the wind all the time from
the most unfavourable quarter has at last increased to a
gale, driving the ship from her course towards we know
not what islands and rocks.... The waves are rolling wildly,
scowling rain clouds begird the horizon and shut out the
sky above us and the view before us. It is now three days
since the captain has been able to get an observation, and
the dead reckoning is in these seas little to be depended
upon, owing to the strong currents. Our situation is no
more safe than it is agreeable.... Every wave rolls us also
to and fro, so that if one sits or stands he is obliged to be
continually bracing himself, now this way, now that, to
keep the center of gravity; and every now and then is
pitched by some sudden lurch against the nearest object
so that sides and arms and elbows fairly ache with the
bruises.... And all this time there is in your ears the
creaking of the rudder chains and the dismal splashing of
the great waves as they surge up under the stern
windows. But a greater annoyance yet remains to be
spoken of. The deck over us (the roof of our cabin) leaks
in a hundred different places upon us, not in drops but in
streams. In my compartment there is but one dry place,
and that is the mattress; and even that is not wholly dry,
for now and then it drops down upon the pillow. The floor
is as wet as if being mopped; wet trunks, wet books, wet
baskets lie around. The chairs are too wet to sit upon, and
so the bed is the only place for rest.”
SCIENTIFIC INTERESTS